Search

everythinglearnresearchcommunity

for

Search:↓

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

The treatment was ineffective in humans.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.